SRTS stock icon

Sensus Healthcare
SRTS

$5.80
1.67%

Market Cap: 95.1M

 

About: Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Employees: 35

0
Funds holding %
of 6,702 funds
Analysts bullish %
0
News positive %
of 3 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

57% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 7

39% more capital invested

Capital invested by funds: $6.62M [Q4 2023] → $9.2M (+$2.58M) [Q1 2024]

10% more funds holding

Funds holding: 40 [Q4 2023] → 44 (+4) [Q1 2024]

2.03% less ownership

Funds ownership: 17.06% [Q4 2023] → 15.03% (-2.03%) [Q1 2024]

27% less call options, than puts

Call options by funds: $8K | Put options by funds: $11K

69% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 16

Research analyst outlook

2 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$10
72%
upside
Avg. target
$10
72%
upside
High target
$10
72%
upside

2 analyst ratings

positive
100%
neutral
0%
negative
0%
HC Wainwright & Co.
Yi Chen
72%upside
$10
Buy
Maintained
13 May 2024
Maxim Group
Anthony Vendetti
72%upside
$10
Buy
Maintained
10 May 2024

Financial journalist opinion

Based on 3 articles about SRTS published over the past 30 days